Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
about
Cannabinoids in health and diseaseThe endocannabinoid system as an emerging target of pharmacotherapyFunctional role of cannabinoid receptors in urinary bladder.Management of fibromyalgia syndrome: review of evidence.A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideCB(1) cannabinoid receptors and their associated proteins.Cannabinoids:their role in pain and palliation.Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.The use of cannabinoids in chronic pain.Examining the roles of cannabinoids in pain and other therapeutic indications: a review.Is there any clinically relevant cannabinoid-induced analgesia?Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Using cannabinoids in pain and palliative care.Cannabinoids in the management of difficult to treat painThe Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity.Is the WHO analgesic ladder still valid? Twenty-four years of experience.An open-label comparison of nabilone and gabapentin as adjuvant therapy or monotherapy in the management of neuropathic pain in patients with peripheral neuropathy.L’échelle analgésique de l’OMS convient-elle toujours?: Vingt-quatre années d’expérience.Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort.
P2860
Q24633884-BC06908C-FFD9-4F11-8141-7596E00BFE3EQ24648473-F3C1090A-BE44-4A4C-B949-583E138BE95DQ33884859-A5FF6124-BF40-4E4B-A3BA-55CB9C23747BQ33938302-4B40E6AC-77B5-4DC6-A076-B550E651A5E8Q34013540-C6E111D3-C6A8-4465-9EFB-1C59AB381F77Q34019573-B62B03B0-29B8-4BAF-B717-2E0C6DDABC00Q35232109-534339D4-51F7-49F6-B0E4-AAFFE7C9B45CQ37010970-100B52B4-581B-4F4B-8BD0-0CB7C588D575Q37038999-1B46AF47-208E-41E5-913F-FC0050EB2BD4Q37077863-6E6333EF-96D7-4B55-8F59-AF0EB569CE2EQ37650292-BD7C6DC8-BF62-4F64-96CF-A77AFCF82786Q38003023-8117CC75-F18F-47A8-8540-B01D9CF723B5Q38503842-4DE39834-2ED8-437C-B14F-43ADA69E0BEBQ39278073-BF1E6672-C64F-41E9-879E-37ADF79A23C6Q41687142-63834B26-C82E-4D8A-A88A-F869C68E47CAQ42016603-1C4386B8-97C3-4C01-A77C-8D51947CE10FQ42734195-EE52ECB3-3668-42E4-936F-0FE108D9529FQ44544970-0EA7DD20-E08A-41CF-B374-B4115ADEE502Q46797807-724BC1CF-435D-4701-8A2F-D30CCE75E5E6Q55333056-C0384CA0-1CC8-4A46-81F8-1BC3292E5009
P2860
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@ast
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@en
type
label
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@ast
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@en
prefLabel
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@ast
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@en
P2093
P2860
P1433
P1476
Experience with the synthetic cannabinoid nabilone in chronic noncancer pain.
@en
P2093
David M Berlach
Mark A Ware
Yoram Shir
P2860
P356
10.1111/J.1526-4637.2006.00085.X
P577
2006-01-01T00:00:00Z